TNNT2 and hypertensive disorder: The 3-month rate was significantly higher than that in the normal hs-cTnT group (P = 0.009).After adjusting for age, sex, hypertension, renal impairment, and NIHSS score on admission,3-month mortality in the elevated hs-cTnT group was 5.5-fold higher (95%CI1.062 to 28.448,P = 0.042) than in the normal hs-cTnT group (Table 4).The two groups did not, however, differ significantly in mortality rate at 6 months (P = 0.292) or 1 year (P = 0.311).